139 related articles for article (PubMed ID: 20404513)
1. Measurement of ATP6V1C1 expression in brush cytology samples as a diagnostic and prognostic marker in oral squamous cell carcinoma.
Pérez-Sayáns M; Reboiras-López MD; Somoza-Martín JM; Barros-Angueira F; Diz PG; Rey JM; García-García A
Cancer Biol Ther; 2010 Jun; 9(12):1057-64. PubMed ID: 20404513
[TBL] [Abstract][Full Text] [Related]
2. Expression of ATP6V1C1 during oral carcinogenesis.
Oliveira Alves MG; Carta CF; Padín-Iruegas ME; Pérez-Sayáns M; Suarez-Peñaranda JM; Issa JS; García-García A; Almeida JD
Biotech Histochem; 2016; 91(4):263-8. PubMed ID: 26984774
[TBL] [Abstract][Full Text] [Related]
3. A prototype tobacco-associated oral squamous cell carcinoma classifier using RNA from brush cytology.
Kolokythas A; Bosman MJ; Pytynia KB; Panda S; Sroussi HY; Dai Y; Schwartz JL; Adami GR
J Oral Pathol Med; 2013 Oct; 42(9):663-9. PubMed ID: 23590359
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
5. Salivary MMP-9 in the detection of oral squamous cell carcinoma.
Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; Hennings J; Schultze-Mosgau S
Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e270-275. PubMed ID: 28160595
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of C1 subunit of V-ATPase (ATPase C1) in oral squamous cell cancer and normal oral mucosa.
García-García A; Pérez-Sayáns M; Rodríguez MJ; Antúnez-López J; Barros-Angueira F; Somoza-Martín M; Gándara-Rey JM; Aguirre-Urízar JM
Biotech Histochem; 2012 Feb; 87(2):133-9. PubMed ID: 21526910
[TBL] [Abstract][Full Text] [Related]
8. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytokeratin 17 mRNA in oral squamous cell carcinoma cells obtained by brush biopsy: preliminary results.
Toyoshima T; Koch F; Kaemmerer P; Vairaktaris E; Al-Nawas B; Wagner W
J Oral Pathol Med; 2009 Jul; 38(6):530-4. PubMed ID: 19222712
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care oral cytology tool for the screening and assessment of potentially malignant oral lesions.
McRae MP; Modak SS; Simmons GW; Trochesset DA; Kerr AR; Thornhill MH; Redding SW; Vigneswaran N; Kang SK; Christodoulides NJ; Murdoch C; Dietl SJ; Markham R; McDevitt JT
Cancer Cytopathol; 2020 Mar; 128(3):207-220. PubMed ID: 32032477
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
12. MUC4: a novel prognostic factor of oral squamous cell carcinoma.
Hamada T; Wakamatsu T; Miyahara M; Nagata S; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Int J Cancer; 2012 Apr; 130(8):1768-76. PubMed ID: 21618516
[TBL] [Abstract][Full Text] [Related]
13. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
[TBL] [Abstract][Full Text] [Related]
15. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
[TBL] [Abstract][Full Text] [Related]
17. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
19. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
[TBL] [Abstract][Full Text] [Related]
20. Nucleus Accumbens-Associated Protein 1 Expression Has Potential as a Marker for Distinguishing Oral Epithelial Dysplasia and Squamous Cell Carcinoma.
Sekine J; Nakatani E; Ohira K; Hideshima K; Kanno T; Nariai Y; Kagimura T; Urano T
PLoS One; 2015; 10(7):e0131752. PubMed ID: 26172271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
